Volume 21, Issue 3, Pages (September 1998)

Slides:



Advertisements
Similar presentations
The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells  Jungsook Cho, Donna L. Gruol  Journal of.
Advertisements

Volume 48, Issue 6, Pages (June 2011)
Volume 68, Issue 4, Pages (October 2005)
Figure 8. Colocalization of β-Arrestin2-GFP with Internalized wt and S(483–498)A Mutant PTHRs HEK-wt PTHR and HEK-S(483–498)A PTHR cells were transiently.
Okadaic-Acid-Induced Inhibition of Protein Phosphatase 2A Produces Activation of Mitogen-Activated Protein Kinases ERK1/2, MEK1/2, and p70 S6, Similar.
by Wei Zhang, and Robert W. Colman
A Role for PML3 in Centrosome Duplication and Genome Stability
W. L. Parker, M. D. , Ph. D. , K. W. Finnson, Ph. D. , H. Soe-Lin, B
Volume 22, Issue 4, Pages (April 1999)
Volume 9, Issue 5, Pages (November 1998)
Volume 4, Issue 3, Pages (September 2006)
Volume 69, Issue 4, Pages (February 2006)
Volume 123, Issue 1, Pages (July 2002)
Volume 13, Issue 4, Pages (February 2003)
Volume 98, Issue 1, Pages (July 1999)
Live Cell Fluorescence Imaging of T Cell MEKK2
Lori Redmond, Amir H. Kashani, Anirvan Ghosh  Neuron 
by Xingwei Sui, Sanford B. Krantz, Min You, and Zhizhuang Zhao
NMDA Induces Long-Term Synaptic Depression and Dephosphorylation of the GluR1 Subunit of AMPA Receptors in Hippocampus  Hey-Kyoung Lee, Kimihiko Kameyama,
Volume 122, Issue 5, Pages (May 2002)
AMP Is a True Physiological Regulator of AMP-Activated Protein Kinase by Both Allosteric Activation and Enhancing Net Phosphorylation  Graeme J. Gowans,
Signal-Dependent Translocation of Transducin, RGS9-1-Gβ5L Complex, and Arrestin to Detergent-Resistant Membrane Rafts in Photoreceptors  K.Saidas Nair,
ASK1 Is Essential for JNK/SAPK Activation by TRAF2
Oocytes Progress beyond Prophase in the Presence of DNA Damage
Volume 15, Issue 1, Pages (January 2012)
Akio Horiguchi, Mototsugu Oya, Ken Marumo, Masaru Murai 
Yongli Bai, Chun Yang, Kathrin Hu, Chris Elly, Yun-Cai Liu 
Plasminogen-Dependent Matriptase Activation Accelerates Plasmin Generation by Differentiating Primary Human Keratinocytes  Ya-Wen Chen, Shi Yin, Ying-Jung.
The Spinal Muscular Atrophy Disease Gene Product, SMN, and Its Associated Protein SIP1 Are in a Complex with Spliceosomal snRNP Proteins  Qing Liu, Utz.
Volume 68, Issue 4, Pages (October 2005)
Volume 17, Issue 6, Pages (December 1996)
Volume 82, Issue 7, Pages (October 2012)
Volume 20, Issue 4, Pages (April 2004)
A JNK-Dependent Pathway Is Required for TNFα-Induced Apoptosis
Volume 7, Issue 5, Pages (November 1997)
Volume 27, Issue 3, Pages (September 2000)
Role of the regulatory domain of the EGF-receptor cytoplasmic tail in selective binding of the clathrin-associated complex AP-2  Werner Boll, Andreas.
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Histamine Inhibits the Production of Interferon-induced Protein of 10 kDa in Human Squamous Cell Carcinoma and Melanoma  Naoko Kanda, Shinichi Watanabe 
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Cyclooxygenase-2 Inhibitor Enhances Whereas Prostaglandin E2Inhibits the Production of Interferon-Induced Protein of 10 kDa in Epidermoid Carcinoma A431 
Volume 5, Issue 6, Pages (June 2004)
Volume 13, Issue 1, Pages (January 2008)
Lee-Ann H. Allen, J.Aaron Allgood  Current Biology 
Volume 11, Issue 1, Pages (July 1999)
Interleukin-6-Resistant Melanoma Cells Exhibit Reduced Activation of STAT3 and Lack of Inhibition of Cyclin E-Associated Kinase Activity  Markus Böhm,
Volume 3, Issue 2, Pages (February 2006)
Volume 8, Issue 5, Pages (November 2008)
Signaling Events During Induction of Plasminogen Activator Inhibitor-1 Expression by Sphingosylphosphorylcholine in Cultured Human Dermal Fibroblasts 
Volume 34, Issue 6, Pages (June 2002)
Volume 109, Issue 6, Pages (June 2002)
Volume 86, Issue 5, Pages (September 1996)
Volume 40, Issue 1, Pages (September 2003)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Kinase Suppressor of Ras Is Ceramide-Activated Protein Kinase
Integrin α3β1 (CD 49c/29) Is a Cellular Receptor for Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) Entry into the Target Cells  Shaw M. Akula,
Volume 70, Issue 5, Pages (September 2006)
Cytotoxic T Lymphocyte Antigen-4 Accumulation in the Immunological Synapse Is Regulated by TCR Signal Strength  Jackson G. Egen, James P. Allison  Immunity 
Volume 55, Issue 2, Pages (February 1999)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Frank S Lee, Jeremiah Hagler, Zhijian J Chen, Tom Maniatis  Cell 
RhoA GTPase Regulates B Cell Receptor Signaling
Volume 3, Issue 4, Pages (April 1999)
Volume 34, Issue 2, Pages (April 2002)
Volume 21, Issue 4, Pages (October 1998)
Volume 23, Issue 2, Pages (August 2005)
Volume 19, Issue 1, Pages (July 1997)
A. A. Honokiol inhibits TNF-induced NF-κB activation, IκBα phosphorylation, and IκBα degradation. Honokiol inhibits TNF-induced activation of NF-κB. H1299.
Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival  K. Virdee, P.A. Parone, A.M. Tolkovsky  Current.
Role for cyclin-dependent kinase 2 in mitosis exit
Presentation transcript:

Volume 21, Issue 3, Pages 495-504 (September 1998) Phosphorylation and Inhibition of Olfactory Adenylyl Cyclase by CaM Kinase II in Neurons  Jia Wei, Allan Z. Zhao, Guy C.K. Chan, Lauren P. Baker, Soren Impey, Joseph A. Beavo, Daniel R. Storm  Neuron  Volume 21, Issue 3, Pages 495-504 (September 1998) DOI: 10.1016/S0896-6273(00)80561-9

Figure 1 Western Analysis for AC3 and CaMKII in Mouse Olfactory Cilia Olfactory cilia were submitted to Western analysis for AC3 (A) or CaMKII (B) as described in Experimental Procedures. (A) Protein samples were not treated (lane 1), incubated with glycosidase buffer only at 37°C (lane 2), or incubated with the glycosidase PNGase F (37°C) before Western analysis (lane 3). (B) The CaMKII antibody was pretreated with (lane 1) or without (lane 2) purified CaMKII protein (1 μg/ml) before Western analysis. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 2 Confocal Microscope Double-Labeled Images of AC3 (red), CaMKII (Green), and Merged Signals (Yellow) Showing Colocalization of AC3 and CaMKII in Mouse Olfactory Cilia Anti-AC3 antibody primarily labeled olfactory cilia. Anti-CaMKII antibodies labeled olfactory cilia and axon bundles. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 3 Citralva Stimulates the Rapid Phosphorylation of AC3 in Mouse Olfactory Cilia Mouse cilia (20 μg) were treated with 10 μM citralva and subjected to Western analysis using an antibody against AC3 phosphorylated at Ser-1076 (AC3P) or an antibody for AC3 as described in Experimental Procedures. The blot was first probed with AC3P (A), stripped, and then reprobed with anti-AC3 antibody (B). Phosphorylation of AC3 at its CaMKII phosphorylation site increased within 15 s after the odorant was applied (A) without affecting the amount of AC3 (B). The AC3P-immunoreactive band was eliminated by preadsorption of AC3P with pep-p, against which AC3P was generated (C). The phosphorylated AC3 band was still detectable when AC3P was preadsorbed with the corresponding nonphosphorylated peptide (pep) (D). Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 4 Kinetics for Citralva-Induced Phosphorylation of AC3 (A) Mouse cilia (20 μg) were treated with 10 μM citralva ± 1.0 μM okadaic acid or with 1.0 μM okadaic acid without citralva and subjected to Western analysis using an antibody against AC3 phosphorylated at Ser-1076 (AC3P) as described in Experimental Procedures. Western blots were scanned, and data are normalized relative to controls not treated with okadaic acid or citralva. Data are the average of three independent experiments. When present, okadaic acid was preincubated with cilia for 10 min prior to addition of odorant. (B) Cilia samples were treated with 1.0 μM okadaic acid, 100 nM IA + 1.0 μM okadaic acid, 10 μM citralva + 1.0 μM okadaic acid, or 10 μM forskolin + 1.0 μM okadaic acid for 15 s. Samples were then analyzed for phosphorylation of AC3 as described in (A), and data are reported relative to untreated controls. (C) Cilia samples were treated with 1.0 μM okadaic in the absence or presence of 10 μM IA, 10 μM citralva, or 10 μM forskolin and submitted to sequential immunoprecipitation using the AC3P and AC3 antibodies. These samples were submitted to Western analysis using the AC3 antibody, and the percentage of AC3 phosphorylated at Ser-1076 was estimated as decribed in Experimental Procedures. (D) Primary cultured neurons were treated for 30 s with 100 nM IA, 10 μM citralva, or 10 μM forskolin and then fixed and stained for phosphorylated AC3 by using the AC3P antibody as described in Experimental Procedures. n = 200 neurons for each treatment. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 5 IA Treatment Promotes the Phosphorylation of AC3 in a Subset of Olfactory Neurons Cultured olfactory neurons were treated with IA (100 nM) or forskolin (10 μM) for 2 min, fixed, and stained immunocytochemically for phosphorylated AC3 (phosphoIIIAC, green) and tubulin (red). The representative images show increased phosphorylated AC3 in only one IA-treated neuron out of seven neurons, while the majority of forskolin-treated neurons show increased AC3 phosphorylation. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 6 CaMKII Inhibitors Block Odorant-Stimulated Phosphorylation of AC3 (A) Mouse olfactory cilia were preexposed for 1 hr to various nonmyristylated protein kinase inhibitors and then treated with citralva for 15 s after incubation in phosphorylation buffer for 1 min. Western analysis was performed using the AC3P antibody as described in Experimental Procedures. Lane 1, untreated; lane 2, citralva; lane 3, citralva + PKA-IP; lane 4, citralva + CaMKII-IP; lane 5, citralva + PKC-IP. When present, citralva and kinase inhibitors were at 10 μM. (B) Primary cultures of mouse olfactory neurons were preincubated with protein kinase inhibitors for 1.5 hr and then treated with 100 nM citralva for 30 s. Western blots for AC3P were carried out as described in Experimental Procedures. Lane 1, untreated; lane 2, citralva; lane 3, citralva + KN-62; lane 4, citralva + myristylated PKA-IP; lane 5, citralva + myristylated PKC-IP. When present, citralva was at 100 nM and protein kinase inhibitors were at 20 μM. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 7 Effect of CaMKII and PDE Inhibitors on cAMP Transients in Cultured Olfactory Neurons Mouse primary olfactory neurons were preincubated with 1 mM IBMX (A), 10 μM KN-62 (B), or 20 μM AIP (C) for 1.5 hr before treatment with 100 nM citralva (Cit). The reactions were quenched with 5% TCA after the indicated times. cAMP accumulations were measured as described in Experimental Procedures. The data are the mean ± SD of triplicate assays and are plotted as the increase in cAMP relative to controls without citralva treatment. Similar results were obtained in three independent experiments. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 8 Effects of CaMKII and PDE Inhibitors on Fast cAMP Transients in Cilia Mouse olfactory cilia were pretreated with 1 mM of IBMX for 30 min (A) or 10 μM of CaMKII-IP for 1 hr (B). Cilia were then incubated with reaction mix containing 10 μM citralva (Cit). cAMP concentrations were obtained at millisecond time points and performed using rapid stopped flow analysis. Data are presented as stimulation relative to basal and are averages of triplicates. Similar results were obtained in three independent experiments. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 9 Effects of CaMKII and PDE Inhibitors on Slow cAMP Transients in Cilia The procedure was the same as described in Figure 7 except that cAMP concentrations were measured manually. Data are presented as stimulation relative to basal and are averages of triplicate determinations. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)

Figure 10 Model for Odorant Stimulation of cAMP Transients Activation of odorant receptors increases cAMP and leads to stimulation of CNG. This depolarizes the membrane and increases intracellular Ca2+. It is hypothesized that cAMP increases are attenuated by PDE and CaMKII inhibition of AC3. Neuron 1998 21, 495-504DOI: (10.1016/S0896-6273(00)80561-9)